Coeliac Disease
Coeliac disease is a chronic immune-mediated disorder triggered by dietary gluten in genetically susceptible individuals. It is not a food intolerance, but a condition in which exposure to gluten initiates a sustained immune response that directly damages the small intestinal mucosa. The resulting intestinal injury leads to malabsorption, nutritional deficiency, and systemic manifestations that often extend far beyond the gastrointestinal tract.
What You Need to Know
Coeliac disease is an immune-mediated disorder in which ingestion of gluten triggers chronic inflammation of the small intestinal mucosa. The small intestine is the primary site of nutrient absorption and relies on intact villi and microvilli to provide a large absorptive surface area. In coeliac disease, an abnormal immune response to gluten damages this architecture, leading to villous atrophy, crypt hyperplasia, and impaired epithelial function. As absorptive surface area is lost, the intestine becomes progressively less able to absorb nutrients effectively.
This mucosal injury persists as long as gluten exposure continues. Ongoing inflammation disrupts digestion, absorption, and barrier integrity, allowing malabsorption to develop across multiple nutrient classes. Importantly, the extent of histological damage does not reliably correlate with symptom severity. Significant villous atrophy and nutritional deficiency may be present even in individuals with mild, intermittent, or absent gastrointestinal symptoms.
Several key features characterise the disease process and help explain its variable presentation:
immune-mediated destruction of villi leading to reduced absorptive surface area
impaired absorption of iron, folate, calcium, and fat-soluble vitamins due to mucosal injury
persistence of intestinal damage despite minimal symptoms when gluten exposure continues
Because coeliac disease affects the intestine at a structural and functional level, its consequences extend beyond the gastrointestinal tract. Chronic malabsorption contributes to anaemia, bone disease, fatigue, and impaired immune function, and may affect growth or fertility in some individuals. Early recognition and sustained removal of gluten are essential to allow mucosal healing, restore absorption, and prevent long-term complications, even when symptoms appear mild or non-specific.
Beyond the Basics
Genetic susceptibility and antigen presentation
Coeliac disease develops only in individuals with specific genetic variants that influence how antigens are presented to the immune system. These variants alter antigen presentation within the intestinal mucosa so that gluten-derived peptides are recognised as harmful rather than tolerated. This shifts the immune response toward inflammation instead of immune tolerance.
Genetic susceptibility alone is not sufficient to cause disease. Coeliac disease emerges from the interaction between genetic risk, ongoing gluten exposure, and dysregulated immune responses within the small intestine. Without gluten exposure, the inflammatory cascade does not activate, even in genetically susceptible individuals.
Gluten processing and immune activation
Gluten is incompletely digested in the gastrointestinal tract, leaving peptide fragments that resist enzymatic breakdown. In susceptible individuals, these peptides cross the intestinal epithelium and interact with immune cells in the lamina propria, the immune-rich layer beneath the epithelial surface.
Rather than being ignored or tolerated, gluten peptides trigger activation of T lymphocytes and release of pro-inflammatory cytokines. This immune response is misdirected toward the intestinal tissue itself, meaning the resulting inflammation damages host structures rather than providing protection. Once initiated, this immune activation sustains itself as long as gluten exposure continues.
Villous atrophy and crypt hyperplasia
Chronic immune-mediated injury targets mature enterocytes lining the villi, leading to villous blunting and eventual flattening. As villi regress, the surface area available for nutrient absorption is dramatically reduced, directly impairing intestinal function.
At the same time, crypts undergo hyperplasia as the intestine attempts to compensate by increasing epithelial cell production. These newly generated cells are immature and functionally limited, so structural adaptation occurs without restoration of effective absorption. This explains why increased cellular turnover does not translate into improved nutritional uptake.
Barrier dysfunction and increased intestinal permeability
Inflammation disrupts tight junctions between epithelial cells, weakening the intestinal barrier. This increases permeability and allows additional gluten peptides and luminal antigens to pass into the mucosa, further stimulating immune activation. Barrier dysfunction and immune injury reinforce one another, creating a self-perpetuating cycle. Ongoing antigen exposure prevents resolution of inflammation, meaning mucosal healing cannot occur while gluten remains present in the diet.
Patterns of malabsorption and nutrient deficiency
Villous atrophy in coeliac disease particularly affects absorption of iron, folate, calcium, and fat-soluble vitamins. This reflects both the anatomical location of injury within the proximal small intestine and the dependence of these nutrients on intact absorptive surfaces. As a result, coeliac disease may first present with iron-deficiency anaemia, osteoporosis, neuropathy, or reproductive dysfunction rather than gastrointestinal symptoms. Malabsorption may remain clinically silent until deficiencies become advanced, contributing to delayed diagnosis.
Systemic effects of ongoing inflammation
Inflammatory mediators generated within the gut can enter the systemic circulation, contributing to fatigue, reduced bone density, and extra-intestinal manifestations. Dermatological, neurological, hepatic, and endocrine features arise from the combined effects of immune dysregulation and chronic nutrient deficiency rather than direct gluten exposure outside the gastrointestinal tract. These systemic effects highlight that coeliac disease is not confined to the intestine, even though intestinal injury is central to its pathophysiology.
Requirement for antigen removal
Unlike other inflammatory intestinal conditions, coeliac disease cannot enter remission while the triggering antigen remains present. Anti-inflammatory or immunosuppressive therapies alone cannot restore mucosal integrity because the immune stimulus persists.
Removal of gluten eliminates the antigen driving immune activation, allowing inflammation to subside and villi to regenerate gradually. Strict, lifelong gluten exclusion is therefore a pathophysiological necessity rather than a symptomatic or lifestyle intervention.
Long-term consequences of untreated disease
Persistent immune activation and accelerated epithelial turnover increase the risk of long-term complications, including refractory coeliac disease and intestinal malignancy. Risk correlates more strongly with duration of untreated disease than with symptom severity. This explains why individuals with minimal or absent gastrointestinal symptoms may still be at significant risk of complications, reinforcing the importance of early diagnosis and sustained mucosal healing.
Clinical Connections
Coeliac disease may present with diarrhoea, bloating, and weight loss, but many individuals present primarily with extraintestinal features such as iron-deficiency anaemia, osteoporosis, infertility, or neurological symptoms. These presentations reflect chronic malabsorption and systemic immune effects rather than gastrointestinal inflammation alone. Because symptom severity does not correlate reliably with the degree of mucosal injury, significant disease activity may be present even when gastrointestinal symptoms are mild or absent, contributing to delayed recognition.
Diagnosis is based on evidence of immune-mediated intestinal injury rather than symptoms alone. Coeliac disease is identified through characteristic serological markers of immune activation and confirmation of villous atrophy on small intestinal biopsy, demonstrating ongoing mucosal damage in response to gluten exposure. This diagnostic approach reflects the underlying pathophysiology, where immune activation and structural injury persist independently of clinical presentation.
Clinical features that commonly prompt investigation include:
unexplained iron-deficiency anaemia, osteoporosis, or recurrent micronutrient deficiencies
infertility, adverse pregnancy outcomes, or delayed puberty
neurological features such as peripheral neuropathy, ataxia, or cognitive change
Long-term management focuses on preventing immune reactivation rather than treating episodic symptoms. Lifelong exclusion of gluten removes the antigen driving intestinal injury, allowing mucosal healing and restoration of absorption over time. Symptom-based management alone is insufficient, as ongoing low-level gluten exposure can sustain inflammation and increase the risk of complications even in the absence of overt symptoms. Linking clinical features back to immune-mediated mucosal damage supports early diagnosis, sustained dietary adherence, and prevention of long-term systemic consequences.
Concept Check
Why does coeliac disease occur only in genetically susceptible individuals?
How does villous atrophy impair absorption despite adequate dietary intake?
Why are iron and calcium deficiencies common early features?
How does increased intestinal permeability perpetuate inflammation?
Why is gluten exclusion essential for mucosal healing?